Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Boosts ImClone Funding To Accelerate Erbitux Development

Jul 31 2007

• By Pamela Taulbee

Related Content

Erbitux Gets Priority Review For Third-Line Colorectal Cancer Claim

Jun 11 2007

Vectibix Vs. Erbitux: The Race For A First-Line Colorectal Cancer Indication

Jan 26 2007

Erbitux Shows Survival Benefit With Chemo In First-Line Metastatic Head &amp; Neck Cancer

Apr 04 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window